ATRYS D2019-OCTUBRE

Trading sesion


07/11/2019 Close

0.0210

Last price


0.45 mill. €

Capitalisation

-46.15

Dif.(%)


-44.00

% Year 2019

Excluded 08/11/2019

Last Trade

Date

07/11/2019

Hour

Close

Last

0.0210

Ref.

0.0390

Dif.(%)

-46.15

Volume (Shares)

6,403,576

Turnover (€x1000)

101.28

Security

Security name

ATRYS D2019-OCTUBRE

Ticker

ATR.D

ISIN

ES0605148917

NIF

A-84942150

Shares Admitted

21.555.051

Nominal

-

Capital Admitted

-

Trading

Continuo

Liquidity Provider

GVC GAESCO VALORES, S.V., S.A.

Registered Advisor

-

Auditor

KPMG AUDITORES, S.L

Address

PRíNCIPE DE VERGARA 132, 28002 MADRID

Contact

relacioninversores@atryshealth.com

Historical Summary

 2019 until 7/11

Capital Admitted (thousands of euros)

n/a

Shares (x 1,000)

21,555

Period Close Price (euros)

0.0210

Period Last Price (euros)

0.0210

Period High Price (euros)

0.1590

Period Low Price (euros)

0.0100

Capitalisation (thousands of euros)

453

Volume (thousands of shares)

12,846

Turnover (thousands of euros)

341

"ATRYS Health specializes in innovative medical diagnostic imaging.and personalized cancer diagnosis and treatments in advanced single-dose radiation therapy company. Our commitment to R & D puts us at the forefront of individualized medicine ."

 

Company Profile

Atrys Health (BME:ATRY), founded in 2015, is a global medical services provider with more than 2,200 professionals and presence in 8 countries. A pioneer in the fields of telemedicine and state-of-the-art radiotherapy, it has a solid track record of organic and inorganic growth with the integration of 14 companies since 2018.

Atrys focuses its activity around three business units: prevention, diagnosis and oncology. Through these three areas, provides a 360º service, covering everything from prevention to cancer treatment, including precision diagnosis and the use of telemedicine. Thus, the company performs diagnostic tests, analyses using telemedicine tests on radiology, cardiology, ophthalmology and dermatology and provides medical oncology services carrying out chemotherapy, immunotherapy and advanced radiotherapy treatments.

Inside Information

Other Relevant Information

Notices

Relevant Facts until 10/05/2020

Significant participations

Financial Reports

Photo Gallery

To obtain detailed information or information in other formats, please contact BME Market Data at marketdata@grupobme.es or visit the website www.bmemarketdata.es.

The information provided by the different websites of Grupo BME is for internal use only. For any commercial use and/or other usage that involves the redistribution of the information to third parties for a fee, it is required a prior and express permission from BME Market Data. Please contact us at marketdata@grupobme.es.